Open access · CC-BY
via OpenAlex
Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status
Amy Cameron, Vicky Louise Morrison, Daniel Levin, Mohapradeep Mohan, Calum Forteath, Craig Beall, Alison D. McNeilly, David J.K. Balfour, Terhi Savinko, Aaron Wong, Benoît Viollet, Kei Sakamoto, Susanna Carola Fagerholm, Marc Foretz, Chim Choy Lang
Circulation Research · 2016 · ▲ 717 citations
Abstract
RATIONALE: The diabetes mellitus drug metformin is under investigation in cardiovascular disease, but the molecular mechanisms underlying possible benefits are poorly understood. OBJECTIVE: Here, we have studied anti-inflammatory effects of the drug and their relationship to antihyperglycemic properties. METHODS AND RESULTS: In primary hepatocytes from healthy animals, metformin and the IKKβ (inhibitor of kappa B kinase) inhibitor BI605906 both inhibited tumor necrosis factor-α-dependent IκB degradation and expression of proinflammatory mediators interleukin-6, interleukin-1β, and CXCL1/2 (C-X-C motif ligand 1/2). Metformin suppressed IKKα/β activation, an effect that could be separated from some metabolic actions, in that BI605906 did not mimic effects of metformin on lipogenic gene expression, glucose production, and AMP-activated protein kinase activation. Equally AMP-activated protein kinase was not required either for mitochondrial suppression of IκB degradation. Consistent with discrete anti-inflammatory actions, in macrophages, metformin specifically blunted secretion of proinflammatory cytokines, without inhibiting M1/M2 differentiation or activation. In a large treatment naive diabetes mellitus population cohort, we observed differences in the systemic inflammation marker, neutrophil to lymphocyte ratio, after incident treatment with either metformin or sulfonylurea monotherapy. Compared with sulfonylurea exposure, metformin reduced the mean log-transformed neutrophil to lymphocyte ratio after 8 to 16 months by 0.09 U (95% confidence interval, 0.02-0.17; P=0.013) and increased the likelihood that neutrophil to lymphocyte ratio would be lower than baseline after 8 to 16 months (odds ratio, 1.83; 95% confidence interval, 1.22-2.75; P=0.00364). Following up these findings in a double-blind placebo controlled trial in nondiabetic heart failure (trial registration: NCT00473876), metformin suppressed plasma cytokines including the aging-associated cytokine CCL11 (C-C motif chemokine ligand 11). CONCLUSION: We conclude that anti-inflammatory properties of metformin are exerted irrespective of diabetes mellitus status. This may accelerate investigation of drug utility in nondiabetic cardiovascular disease groups. CLINICAL TRIAL REGISTRATION: Name of the trial registry: TAYSIDE trial (Metformin in Insulin Resistant Left Ventricular [LV] Dysfunction). URL: https://www.clinicaltrials.gov. Unique identifier: NCT00473876.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1161/circresaha.116.308445
- Canonical
- link ↗
- Fetched
- 2026-11-11 MST
Cite this
APA
Cameron, A., Morrison, V.L., Levin, D., Mohan, M., Forteath, C., Beall, C., McNeilly, A.D., Balfour, D.J., Savinko, T., Wong, A., Viollet, B., Sakamoto, K., Fagerholm, S.C., Foretz, M., Lang, C.C., & Rena, G. (2016). Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status. <em>Circulation Research</em>. https://doi.org/10.1161/circresaha.116.308445
Vancouver
Cameron A, Morrison VL, Levin D, Mohan M, Forteath C, Beall C, et al. Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status. Circulation Research. 2016. doi:10.1161/circresaha.116.308445.
BibTeX
@article{amy2016AntiIn,
title = {Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status},
author = {Amy Cameron and Vicky Louise Morrison and Daniel Levin and Mohapradeep Mohan and Calum Forteath and Craig Beall and Alison D. McNeilly and David J.K. Balfour and Terhi Savinko and Aaron Wong and Benoît Viollet and Kei Sakamoto and Susanna Carola Fagerholm and Marc Foretz and Chim Choy Lang and Graham Rena},
journal = {Circulation Research},
year = {2016},
doi = {10.1161/circresaha.116.308445},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
BMC Systems Biology 2019
Open access · CC-BY
Effects of unpaired 1 gene overexpression on the lifespan of Drosophila melanogaster
Scientific Reports 2021
Open access · CC-BY
Metformin selectively dampens the acute inflammatory response through an AMPK-dependent mechanism
Diabetes Care 2012
Open access · CC-BY
Arterial Stiffness Is Increased in Patients With Type 1 Diabetes Without Cardiovascular Disease
Journal of Hypertension 2007
Citation only
Relationship of fibrinogen with arterial stiffness and wave reflections
Diabetologia 2017
Open access · CC-BY
The mechanisms of action of metformin
The Journals of Gerontology Series A 2013
Open access · OA